Intended for healthcare professionals

  1. Research
  2. Clinical value of the...
  3. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
Research

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.38766.624097.1F (Published 13 April 2006) Cite this as: BMJ 2006;332:878

Data supplement

  •  


     

    Posted as supplied by author.

    Appendix Table A. Metabolic Syndrome Criteria Fulfilled at Ages 50 and 70 in the Total Sample

    Age

    50

    70

    Metabolic syndrome criteria

    NCEP criteria

    WHO criteria

    NCEPBMI

    WHOHOMA

    NCEPWAIST

    NCEPBMI

    WHOCLAMP

    WHOHOMA

    Subjects with metabolic syndrome, n

    405

    270

    294

    282

    520

    258

    Impaired glucose metabolism

    Fasting p-glucose ≥6.1 mmol/l

    IGT, IFG or diabetes mellitus and/or insulin resistance

    206 (51)

    219 (100)

    146 (50)

    146 (52)

    520 (100)

    258 (100)

    Hypertension

    Blood pressure ≥130/85 mmHg or Rx

    Blood pressure ≥140/90 mmHg or Rx

    385 (95)

    259 (96)

    288 (98)

    277 (98)

    468 (90)

    250 (97)

    Dyslipidemia

    Triglycerides ≥1.7 mmol/l

    Triglycerides ≥1.7 mmol/l and/or HDL cholesterol <0.91 mmol/l

    387 (96)

    259 (96)

    215 (73)

    210 (74)

    246 (47)

    202 (78)

    HDL cholesterol <1.04 mmol/l

    210 (52)

    191 (65)

    183 (65)

    Central obesity

    BMI>29.4 kg/m2

    Waist/hip ratio >0.9 and/or BMI >30 kg/m2

    142 (35)

    87 (32)

    -

    139 (49)

    490 (94)*

    121 (47)

    Waist circumference >102 cm

    -

    145 (49)

    -

    Target organ damage

    -

    Microalbuminuria (urinary albumin excretion rate ≥20 µg/min)

    -

    -

    -

    -

    116 (22)

    -

    Data are numbers of individuals (percent) fulfilling the metabolic syndrome criteria according to the various definitions. *, For ease of comparison between the two ages, the modified WHOHOMA definitions are identical at ages 50 and 70, but the WHOCLAMP definition at age 70 also includes the waist/hip ratio and microalbuminuria criteria (see Table 1). NCEP, National Cholesterol Education Program; WHO, World Health Organisation; HOMA, homeostasis model assessment; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; Rx, treatment; HDL, high-density lipoprotein; BMI, body mass index.

     

Related articles

See more

Cited by...

  • Different Combinations of the Metabolic Syndrome Criteria and Cardiovascular Disease
  • Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey
  • Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT
  • A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells
  • Cardiometabolic Traits and Systolic Mechanics in the Community
  • Childhood Socioeconomic Status in Predicting Metabolic Syndrome and Glucose Abnormalities in Adulthood: The Cardiovascular Risk in Young Finns Study
  • Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
  • Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study
  • Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals
  • The Bioenergetic Health Index: a new concept in mitochondrial translational research
  • Facons d'identifier et de prendre en charge la dyslipidemie atherogene: Une consequence metabolique de l'obesite et du diabete
  • Approach to identifying and managing atherogenic dyslipidemia: A metabolic consequence of obesity and diabetes
  • Intensity versus duration of physical activity: implications for the metabolic syndrome. A prospective cohort study
  • Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study
  • Sleep apnoea syndrome in 2011: current concepts and future directions
  • A Detailed Cardiovascular Characterization of Obesity Without the Metabolic Syndrome
  • Alternative Healthy Eating Index and mortality over 18 y of follow-up: results from the Whitehall II cohort
  • Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study
  • The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis
  • Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
  • Perioperative Outcomes of Coronary Artery Bypass Grafting: Effects of Metabolic Syndrome and Patient's Sex
  • Sleep, sleep-disordered breathing and metabolic consequences
  • Management of hirsutism
  • Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
  • Association Between Metabolic Syndrome and Depressive Symptoms in Middle-Aged Adults: Results from the Whitehall II study
  • Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts
  • Arterial stiffness and haemodynamic response to vasoactive medication in subjects with insulin-resistance syndrome
  • Low Urine pH: A Novel Feature of the Metabolic Syndrome
  • Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study
  • Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study
  • The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
  • The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes
  • Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up
  • Household Wealth and the Metabolic Syndrome in the Whitehall II Study
  • Metabolic syndrome and risk for heart failure in middle-aged men
  • Risk Associated With the Metabolic Syndrome Versus the Sum of Its Individual Components
  • Predictive value of metabolic syndrome is not clear
  • Metabolic syndrome and mortality
Back to top